Paris-based Chipiron secured €15 million in Series A funding in May 2025. Blast led the round, with participation from the EIC Fund. This investment propels Chipiron's mission to make advanced MRI scans widely accessible.
Advancing Accessible MRI Technology
Chipiron, founded in 2020, develops light, inexpensive, open full-body MRI machines. These innovative medical devices aim to democratize access to critical diagnostic imaging. Current MRI systems are often costly and complex, limiting availability, especially in emerging regions. Consequently, early detection of many deadly diseases remains challenging.
The company's MRI technology provides high-quality imaging without compromising diagnostic accuracy. Previously, Chipiron received support from EIT Health in 2022 and the EIC in 2024. This latest Chipiron funding round further accelerates the development and deployment of their groundbreaking HealthTech solutions. Chipiron's approach contrasts with traditional imaging giants like Philips Healthcare or Canon Medical Systems. Furthermore, their focus on accessibility could impact the broader AI diagnostics landscape.
